Eliano Pio Navarese Selected Research

Factor Xa Inhibitors

8/2013

Low-dose of oral factor Xa inhibitors in patients with a recent acute coronary syndrome: a systematic review and meta-analysis of randomized trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eliano Pio Navarese Research Topics

Disease

24	Myocardial Infarction 10/2023 - 08/2006
20	Acute Coronary Syndrome 01/2024 - 01/2011
17	ST Elevation Myocardial Infarction 11/2023 - 01/2011
16	Hemorrhage 10/2023 - 01/2011
13	Thrombosis (Thrombus) 01/2023 - 11/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2011
4	Stroke (Strokes) 10/2023 - 01/2013
4	Infarction (Infarctions) 01/2014 - 11/2011
3	COVID-19 01/2023 - 01/2021
3	Heart Failure 01/2023 - 01/2023
3	Unstable Angina 01/2022 - 08/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 08/2015
3	Inflammation (Inflammations) 09/2013 - 08/2006
2	Cardiogenic Shock 11/2023 - 01/2021
2	Left Ventricular Dysfunction 01/2023 - 07/2012
2	Atrial Fibrillation 01/2023 - 01/2012
2	Coma (Comas) 01/2021 - 03/2013
2	Out-of-Hospital Cardiac Arrest 01/2021 - 03/2013
2	Anemia 01/2017 - 01/2017
2	Stable Angina 07/2014 - 01/2013
2	Diabetes Mellitus 04/2014 - 04/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2011 - 04/2007
1	Ventricular Dysfunction 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Atherosclerotic Plaque (Atheroma) 05/2022
1	Thrombophilia 01/2021
1	Acute Lung Injury 01/2021
1	Rupture 02/2020
1	Pathologic Constriction (Stenosis) 10/2019
1	Hypertension (High Blood Pressure) 09/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Hyperplasia 02/2016
1	Hypercholesterolemia 07/2015
1	Dyslipidemias (Dyslipidemia) 07/2015
1	Wound Infection (Wound Infections) 06/2015
1	Non-ST Elevated Myocardial Infarction 01/2015

Drug/Important Bio-Agent (IBA)

8	TicagrelorIBA 10/2023 - 11/2011
8	AnticoagulantsIBA 01/2023 - 08/2006
7	Clopidogrel (Plavix)FDA Link 10/2023 - 01/2011
4	bivalirudin (Angiomax)FDA Link 11/2015 - 03/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 04/2013
4	Glycoproteins (Glycoprotein)IBA 01/2015 - 01/2011
4	Abciximab (ReoPro)FDA Link 01/2014 - 01/2011
4	C-Reactive ProteinIBA 07/2012 - 08/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 01/2021
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 04/2015
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 01/2016
3	Heparin (Liquaemin)FDA LinkGeneric 01/2015 - 03/2014
2	cangrelorIBA 11/2023 - 05/2014
2	sirioIBA 01/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 12/2022 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 01/2017
2	CollagenIBA 06/2015 - 08/2006
2	Adenosine Diphosphate (ADP)IBA 01/2015 - 08/2006
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2014 - 11/2011
2	Eptifibatide (Integrilin)FDA Link 01/2014 - 01/2011
2	Tirofiban (Aggrastat)FDA Link 01/2014 - 01/2011
2	Prasugrel Hydrochloride FDA Link 01/2014 - 11/2011
2	Platelet Membrane Glycoprotein IIbIBA 01/2014 - 01/2011
1	Opioid Analgesics (Opioids)IBA 11/2023
1	Purinergic P2Y Receptor AntagonistsIBA 11/2023
1	RivaroxabanIBA 10/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 01/2023
1	Methoxyflurane (Penthrane)FDA Link 01/2022
1	TroponinIBA 04/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	MetalsIBA 10/2019
1	LDL CholesterolIBA 09/2019
1	Ezetimibe (Zetia)FDA Link 09/2019
1	alirocumabIBA 09/2019
1	oxidized low density lipoproteinIBA 09/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	ProdigyIBA 02/2016
1	omega-Chloroacetophenone (Mace)IBA 08/2015
1	AntibodiesIBA 07/2015
1	Proprotein Convertase 9IBA 07/2015
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 06/2015
1	Thrombin FDA Link 01/2015

Therapy/Procedure

26	Therapeutics 01/2024 - 04/2007
19	Percutaneous Coronary Intervention 01/2023 - 01/2011
11	Stents 10/2019 - 11/2011
4	Drug-Eluting Stents 10/2019 - 11/2011
3	Induced Hypothermia 11/2023 - 03/2013
3	Transcatheter Aortic Valve Replacement 01/2023 - 02/2020
2	Secondary Prevention 04/2017 - 01/2015
2	Thrombectomy 07/2013 - 01/2013
1	Deprescriptions 01/2023
1	Endarterectomy (Thromboendarterectomy) 05/2022
1	Oral Administration 01/2019
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2018
1	Duration of Therapy 02/2016
1	Length of Stay 06/2015